Eli Lilly has not announced a specific approval submission date, but based on typical trial timelines, an FDA submission could come in 2025 or 2026, with potential approval following 6 to 12 months after that
Phase Maintenance Weeks 25+ Retatrutide 12 mg/week Cagrilintide 2.4 mg/week Notes Full four-receptor coverage if tolerated
These agreements typically specify quarterly or monthly order quantities, fixed pricing for an agreed period (usually 6-12 months), quality specifications and testing requirements, payment terms, and dispute resolution procedures
You can discuss these topics with our clinician to determine which medication is right for you
It should be noted that birth control pills may not be as effective while using GLP-1 medications, Gandhi says, so you might want to use a backup method. If you do become inadvertently pregnant while taking a GLP-1, stop using the medication and call your ob-gyn, Gandhi says
Supporting patient autonomy, therefore requires more than simply honoring a request